Modification of certain central nervous effects of haloperidol during long-term treatment in the mouse and rat.
D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000633:toxicity; D000818:Animals; D001921:Brain / Q000378:metabolism; D002375:Catalepsy / Q000139:chemically induced; D002490:Central Nervous System / Q000187:drug effects*; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010424:Pentobarbital / Q000494:pharmacology; D051381:Rats; D012965:Sodium Chloride
D012965:Sodium Chloride; D000661:Amphetamine; D010424:Pentobarbital; D006220:Haloperidol; D004298:Dopamine; D009638:Norepinephrine